Tags: goldman | drug | epidemic | economy | toll

Goldman Economists See Drug Epidemic Taking Toll on US Economy

Goldman Economists See Drug Epidemic Taking Toll on US Economy
(Dollar Photo Club)

Friday, 07 July 2017 11:43 AM

Goldman Sachs Group Inc. economists say America’s opioid epidemic is probably sidelining people in their prime working years and contributing to the stubbornly low rate of men and women who are either employed or looking for jobs.

“Use of both legal prescription pain relievers and illegal drugs is part of the story of declining prime-age participation, especially for men,” Goldman economists wrote in the study released Wednesday.

Prescription drug use has increased dramatically since the late 1990s, while widespread abuse of prescription painkillers has transitioned into illegal use of heroin and fentanyl in recent years as pills become expensive and hard to access. The crisis has pushed up drug deaths while limiting the number of people capable of getting and keeping a job.

Goldman says the epidemic reinforces their doubts about a rebound in America’s lackluster labor participation rate.

The participation rate, or share of working-age people in the labor force, increased to 62.8 percent from 62.7 percent, still near the lowest level in more than three decades, the Bureau of Labor Statistics said Friday.

The U-6 or underemployment rate rose to 8.6 percent from 8.4 percent, the first increase since January; the figure includes part-time workers who’d prefer a full-time position and people who want a job but aren’t actively looking.

At the same time, the Goldman economists say it’s unlikely that the drug epidemic has rendered working-age people sitting on the labor market’s sidelines totally unemployable.

“We see little basis for writing off the remaining unemployed, whose rate of drug use has not risen nearly as much as one might think from the surge in drug deaths,” economist David Mericle wrote in the note.

Mericle also says that the economic impact of the opioid epidemic extends beyond the labor market, noting that a recent estimate put the cost in terms of health care, criminal justice and productivity at $78.5 billion for 2013.

“The crisis has grown significantly since then, implying substantial costs to both employers and the public sector,” according to the report.

© Copyright 2019 Bloomberg News. All rights reserved.

1Like our page
Crisis reinforces doubts about rebound in participation rate; Goldman economists say drug deaths probably overstate impact
goldman, drug, epidemic, economy, toll
Friday, 07 July 2017 11:43 AM
Newsmax Media, Inc.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved